{"id":"W2612252842","doi":"10.1097/01.cot.0000520166.95325.d1","title":"First Drug Approved for Merkel Cell Carcinoma Achieves Strong Response","year":2017,"lang":"en","type":"article","venue":"Oncology Times","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Merkel cell carcinoma; Avelumab; Medicine; Merkel cell polyomavirus; Merkel cell; Cancer; Dermatology; Chemotherapy; Melanoma; Oncology; Carcinoma; Internal medicine; Immunotherapy; Cancer research; Nivolumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003794818,0.0008003035,0.0007069074,0.0006431509,0.0005268774,0.001410674,0.000497463,0.001759956,0.138731],"category_scores_gemma":[0.0008058555,0.0002162408,0.0007732501,0.0004600671,0.0002551509,0.0008333653,0.0005850013,0.002843749,0.09702693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006591731,"about_ca_system_score_gemma":0.0007388924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008455201,"about_ca_topic_score_gemma":0.004344698,"domain_scores_codex":[0.999597,0.0000475288,0.00002308293,0.0000678568,0.0001948389,0.00006967816],"domain_scores_gemma":[0.9996443,0.00002961877,0.00003914061,0.00002902703,0.0001261315,0.0001319192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004541202,0.0003204738,0.000628992,0.0006102566,0.00004758587,0.0002883306,0.00002636215,0.00008713563,0.005824603,0.001980599,0.7018868,0.2878447],"study_design_scores_gemma":[0.0004747463,0.0004570801,0.001554485,0.0001518204,0.0000267354,0.0006752063,0.00001517403,0.000101501,0.001702022,0.0003501034,0.9944793,0.00001189951],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.01633404,0.1092804,0.002241675,0.03358972,0.01708328,0.001182841,0.01176786,0.003935159,0.8045851],"genre_scores_gemma":[0.07764042,0.05044878,0.003543718,0.03924535,0.004089986,0.000548806,0.009648952,0.0004146677,0.8144193],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.138731,"threshold_uncertainty_score":0.4641014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02154805255533929,"score_gpt":0.3117952358933817,"score_spread":0.2902471833380423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}